Join Me After Lunch for a Chat and Live Podcast about Getting Virtual Face...
Virtual Face Time with Physicians A discussion with Asheesh Gupta, M.D., M.P.H., CEO and co-founder of eHyppo, an independent online health care community created by and for health care...
Should I Stop Taking Zetia?
After Merck & Co. and Schering-Plough Corp. admitted that Vytorin -- a combination of Zetia and Zocor (simvastatin) -- worked no better than an older, generic medication to reduce plaques in...
Did Pfizer Run a Chantix “Bookend” Ad During 60 Minutes?
Last night, while watching 60 Minutes on CBS, there was an "NFL Today" playoff update break with James Brown.As the spot came on, Brown first mentioned that the break was sponsored...
FDA DTC Payola Out, You Pay In!
Recent changes to how FDA will be paid to review DTC TV ads forces us to ask: What's worse? Drug companies paying the FDA to preview TV ads for approval or...
Rozerem Deep Sea Diver Debuts in New Yorker Cartoon Contest
I was relaxing leafing through the latest New Yorker magazine while watching Extra on TV, when I came upon this week's New Yorker cartoon caption contest selection (on left).This has GOT...
Jarvik — Lipitor spokesperson — “outed” as an unlicensed physician!
Lately, I've been seeing a lot more of those Dr. Jarvik Lipitor ads on TV and in magazines. When the first version of these ads aired, I thought Jarvik looked like...
Promotion vs. R&Deja vu all over again!
It's deja vu all over again in the ongoing debate of R&D spending vs. promotional spending by the US pharmaceutical industry.Critics are out again to "prove" that the industry spends much...
Giuliani’s OxyContin (and PhRMA) Money
A new article in today's New York Times -- "Under Attack, Drug Maker Turned to Giuliani for Help" rehashes an old story about how presidential candidate Rudy Giuliani earned millions of...
Who Reads Pharma Marketing Blog?
I've been running a survey of readers of this blog for a while (see Pharma Marketing Blog Reader Survey to take the survey). Thank you if you have already taken the...
Is It Time to End Industry Sponsored CME?
Last year, the pharmaceutical industry provided $1.19 billion to sponsor physician continuing medical education (CME) programs in the US ($1.44 billion if you include advertising and exhibits at CME events). See...
